Psychiatric safety associated with hormone replacement therapy for menopausal symptoms
A real-world study of the FDA adverse event reporting system
Bibliographic Data
| ID | 15526397 |
|---|---|
| Authors | Nan Chen (0000-0001-8454-079X, Shenzhen University Health Science Center, corresponding author), Lei Li (0000-0002-0388-7933, Shenzhen Second People's Hospital), Chunli Fu (0000-0003-4378-0863, Qilu Hospital of Shandong University), Chun-li Fu, Yi Ren (0000-0001-8876-5523, Shenzhen Second People's Hospital) |
| Year | 2025 |
| Volume | 16 |
| Pages | 1614087-1614087 |
| Publication date | 2025-06-27 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2025.1614087 |
| PMID | 40656051 |
| OpenAlex | W4411731273 |
| Language | EN |
| References cited | 31 |
It is necessary to conduct personalized risk stratification in HRT management, prioritizing age, administration route, and regimen type. While, further clinical investigations are needed to validate these findings and refine HRT safety strategies
Adverse effect · Adverse Event Reporting System · Confounding · Estrogen · Hormone replacement therapy (female-to-male · Menopause · Odds ratio · Progestogen · Testosterone (patch · Endometriosis Research and Treatment · Estrogen and related hormone effects · Medicine · Menopause: Health Impacts and Treatments · Internal Medicine
| Citation velocity | historical |
|---|---|
| Highly cited | No |